NCT06408480

Neonatologist-performed Lung Ultrasound in the Delivery Room

Name: Clinical Trial NCT06408480
Creator: Medical University of Graz
Keywords: Neonatal Disease, Neonatologist-performed lung ultrasound, diagnostic test, clinical trial, Austria

Neonatologist-performed Lung Ultrasound During Immediate Transition After Birth to Predict the Need for Respiratory Support Persisting More Than 1 Hour - a Pilot Study

Medical University of Graz·ClinicalTrials.gov·diagnostic testRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Neonatal Disease
Drug/Device/Intervention: Neonatologist-performed lung ultrasound
Study type: Observational
Intervention type: diagnostic test

Sponsor & location

Primary sponsor: Medical University of Graz
Location: Graz, Austria

Timeline & enrollment

Phase: N/A
Start date: May 01, 2024
End date: May 31, 2025
Enrollment: 40 participants

Primary outcome

Determination of the change in lung ultrasound score according to Rodriguez-Fanjul et al. 2020,The need for respiratory support persisting more than 1 hour after birth,Admission to the Neonatal Intensive Care Unit

Summary

The objective of this study is to evaluate the role of the neonatologist-performed lung ultrasound (NPLUS) during immediate transition after birth of late preterm and full-term neonates using the lung ultrasound score to predict the need of respiratory support persisting more than 1 hour after birth.

ICD-10 classifications

Neonatal aspiration syndrome, unspecifiedNeonatal comaNeonatal aspiration syndromesRespiratory condition of newborn, unspecifiedNeonatal diabetes mellitus

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06408480
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06408480 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Graz and is currently Recruiting. The study focuses on Neonatal Disease. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.